---
schema_version: "secwatch.filing_event.v1"
accession: "0001459839-25-000005"
form_type: "8-K"
ticker: "SIBN"
cik: "0001459839"
company_name: "SI-BONE, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:07:35.389454+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# SI-BONE preliminary Q4 revenue ~$48.8-49.0M (+26% YoY); turns adjusted EBITDA profitable

## Summary
- Q4 worldwide revenue ~$48.8-49.0M (+26% YoY); US revenue ~$46.7-46.9M (+28%).
- Full year 2024 worldwide revenue ~$167.0-167.1M (+20%) and US revenue ~$158.2-158.4M (+21%).
- Achieved adjusted EBITDA profitability in Q4 2024; cash & securities ~$150M at quarter end.
- Active US physicians rose to ~1,390 (+23% YoY).
- Results are preliminary and subject to adjustment; full earnings call expected late Feb 2025.

## SEC filing metadata
- accession: 0001459839-25-000005
- form_type: 8-K
- ticker: SIBN
- cik: 0001459839
- company_name: SI-BONE, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1459839/000145983925000005/0001459839-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1459839/000145983925000005/sibn-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001459839-25-000005
- JSON: https://secwatch.observer/filing/0001459839-25-000005.json
- Plain text: https://secwatch.observer/filing/0001459839-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.